Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D de la Hamette

Showing results (1-10 of 12) with videos related to

Pageof 2
Sort By:
VASA. Supplementum|January 1, 1991
[Placebo controlled study of the effect of intravenous PGE1 on macro- and microcirculation in patients with stage III/IV arterial occlusive disease]P Scheffler, D de la Hamette, G Leipnitz
VASA. Supplementum|January 1, 1992
[Prostaglandin E1 in intermittent claudication]P Scheffler, D de la Hamette, W Rogatti
VASA. Supplementum|January 1, 1989
Therapeutic efficacy of intravenously applied prostaglandin E1P Scheffler, D de la Hamette, G Leipnitz
VASA. Supplementum|January 1, 1991
[Controlled vascular training in IIb peripheral arterial occlusive disease: additive effect of intravenous PGE1 versus intravenous pentoxifylline during training]P Scheffler, D de la Hamette, H Müller
VASA. Supplementum|January 1, 1988
[Intravenous administration of PGE1: studies of the effectiveness and duration of the effect of various dosages based on flow measurements of the femoral artery in patients with healthy vessels and in stage IIb arterial occlusive disease]P Scheffler, L Birkel, K R Grub, et al.
VASA. Supplementum|January 1, 1988
[Noninvasive, quantitative flow measurement of the femoral artery: significance for the diagnosis and therapy of peripheral arterial occlusive disease]P Scheffler, K R Grub, D De la Hamette, et al.
VASA. Supplementum|January 1, 1991
[A new oral prostaglandin E1 derivative (OP 1206) compared with intravenous PGE1: assessment of the effect on macro- and microcirculation]P Scheffler, D de la Hamette, G Pindur, et al.
Circulation|August 1, 1994
Intensive vascular training in stage IIb of peripheral arterial occlusive disease. The additive effects of intravenous prostaglandin E1 or intravenous pentoxifylline during trainingP Scheffler, D de la Hamette, J Gross, et al.
VASA. Zeitschrift Fur Gefasskrankheiten|January 1, 1990
Coincidence of risk factors and early carotid lesions, detected with modern ultrasound techniquesP Scheffler, G Leipnitz, C Bender, et al.
VASA. Zeitschrift Fur Gefasskrankheiten|January 1, 1994
[Noninvasive studies of macro- and microcirculation in follow-up of femoropopliteal bypass operation in IIb peripheral arterial occlusive disease]P Scheffler, J Gross, S Dabringhaus, et al.
Pageof 2

Showing results (1-10 of 12) with videos related to

Sort By:
Pageof 2
VASA. Supplementum|January 1, 1991
[Placebo controlled study of the effect of intravenous PGE1 on macro- and microcirculation in patients with stage III/IV arterial occlusive disease]P Scheffler, D de la Hamette, G Leipnitz
VASA. Supplementum|January 1, 1992
[Prostaglandin E1 in intermittent claudication]P Scheffler, D de la Hamette, W Rogatti
VASA. Supplementum|January 1, 1989
Therapeutic efficacy of intravenously applied prostaglandin E1P Scheffler, D de la Hamette, G Leipnitz
VASA. Supplementum|January 1, 1991
[Controlled vascular training in IIb peripheral arterial occlusive disease: additive effect of intravenous PGE1 versus intravenous pentoxifylline during training]P Scheffler, D de la Hamette, H Müller
VASA. Supplementum|January 1, 1988
[Intravenous administration of PGE1: studies of the effectiveness and duration of the effect of various dosages based on flow measurements of the femoral artery in patients with healthy vessels and in stage IIb arterial occlusive disease]P Scheffler, L Birkel, K R Grub, et al.
VASA. Supplementum|January 1, 1988
[Noninvasive, quantitative flow measurement of the femoral artery: significance for the diagnosis and therapy of peripheral arterial occlusive disease]P Scheffler, K R Grub, D De la Hamette, et al.
VASA. Supplementum|January 1, 1991
[A new oral prostaglandin E1 derivative (OP 1206) compared with intravenous PGE1: assessment of the effect on macro- and microcirculation]P Scheffler, D de la Hamette, G Pindur, et al.
Circulation|August 1, 1994
Intensive vascular training in stage IIb of peripheral arterial occlusive disease. The additive effects of intravenous prostaglandin E1 or intravenous pentoxifylline during trainingP Scheffler, D de la Hamette, J Gross, et al.
VASA. Zeitschrift Fur Gefasskrankheiten|January 1, 1990
Coincidence of risk factors and early carotid lesions, detected with modern ultrasound techniquesP Scheffler, G Leipnitz, C Bender, et al.
VASA. Zeitschrift Fur Gefasskrankheiten|January 1, 1994
[Noninvasive studies of macro- and microcirculation in follow-up of femoropopliteal bypass operation in IIb peripheral arterial occlusive disease]P Scheffler, J Gross, S Dabringhaus, et al.
Pageof 2